Can a supplement ease asthma in obesity? new study explores MitoQ
NCT ID NCT04026711
First seen Jan 10, 2026 · Last updated Apr 30, 2026 · Updated 14 times
Summary
This early-stage study tested whether MitoQ, a dietary supplement, could improve airway function in 47 obese adults with poorly controlled asthma. Participants took MitoQ or a placebo for 14 weeks. The main goal was to see if MitoQ reduced airway reactivity, a key asthma symptom. Results may guide future research on treating asthma in people with obesity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University
Durham, North Carolina, 27710, United States
-
University of Vermont
Burlington, Vermont, 05405, United States
Conditions
Explore the condition pages connected to this study.